HonCode

Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-28-2008, 09:01 PM   #1
eric
Senior Member
 
Join Date: Sep 2005
Posts: 589
Vaccine Successfully Enters Phase-II Trial

http://www.allheadlinenews.com/articles/7011409961

Washington D.C. (AHN) - A breast cancer vaccine currently being tested in a Phase II trial at various hospitals has yielded positive results and is targeted towards women who've already had metastatic breast cancer.
The therapeutic breast cancer vaccine AE37 uses a peptide antigen of a cancer gene known as HER-2/neu. This gene/protein is present in many types of cells, but it is over-expressed in a high proportion of breast cancers as well as many others.
Researchers say that they are seeking to evaluate the efficacy of two anti-cancer vaccines targeted to the HER 2 protein, which is expressed in 60 to 70 percent of all breast cancers.
Researchers believe that if the woman if an immune responder, she has double the survival rates as compared to non-responder.
eric is offline   Reply With Quote
 

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 04:20 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter